Dashboard
Manage Tickers

LEXXLexaria Bioscience Corp.

Nasdaq www.lexariabioscience.com


$ 3.58 $ 0.06 (1.69 %)    

Thursday, 09-May-2024 15:57:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 3.6
$ 3.80
$ 0.00 x 0
$ 0.00 x 0
$ 3.57 - $ 3.80
$ 0.65 - $ 6.85
192,366
na
37M
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-09-2024 02-29-2024 10-Q
2 01-12-2024 11-30-2023 10-Q
3 11-20-2023 08-31-2023 10-K
4 07-14-2023 05-31-2023 10-Q
5 04-14-2023 02-28-2023 10-Q
6 01-17-2023 11-30-2022 10-Q
7 11-28-2022 08-31-2022 10-K
8 07-14-2022 05-31-2022 10-Q
9 04-11-2022 02-28-2022 10-Q
10 01-14-2022 11-30-2021 10-Q
11 11-27-2021 08-31-2021 10-K
12 07-15-2021 05-31-2021 10-Q
13 04-14-2021 02-28-2021 10-Q
14 01-14-2021 11-30-2020 10-Q
15 10-15-2020 08-31-2020 10-K
16 06-30-2020 05-31-2020 10-Q
17 04-03-2020 02-29-2020 10-Q
18 01-09-2020 11-30-2019 10-Q
19 11-14-2019 08-31-2019 10-K
20 07-08-2019 05-31-2019 10-Q
21 04-15-2019 02-28-2019 10-Q
22 01-11-2019 11-30-2018 10-Q
23 11-14-2018 08-31-2018 10-K
24 07-13-2018 05-31-2018 10-Q
25 04-12-2018 02-28-2018 10-Q
26 01-12-2018 11-30-2017 10-Q
27 11-27-2017 08-31-2017 10-K
28 07-14-2017 05-31-2017 10-Q
29 04-14-2017 02-28-2017 10-Q
30 01-13-2017 11-30-2016 10-Q
31 11-29-2016 08-31-2016 10-K
32 07-13-2016 05-31-2016 10-Q
33 04-13-2016 02-29-2016 10-Q
34 01-08-2016 11-30-2015 10-Q
35 11-27-2015 08-31-2015 10-K
36 07-14-2015 05-31-2015 10-Q
37 04-14-2015 02-28-2015 10-Q
38 01-14-2015 11-30-2014 10-Q
39 09-11-2014 07-31-2014 10-Q
40 06-12-2014 04-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Lexaria Announces New Research Program To ...
05/06/2024 13:08:30

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

Core News & Articles
Lexaria To Receive $4.7M Gross Proceeds In...
04/30/2024 19:53:35

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/16/2024 20:31:56

Core News & Articles
Lexaria Receives Ethics Review Board Appro...
04/16/2024 13:17:08

Human Pilot Study #2 (GLP-1-H24-2) ApprovedKELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(N...

Core News & Articles
Lexaria Appoints Nelson Cabatuan As Chief ...
03/14/2024 13:22:01

Lexaria Bioscience Corp.

why-asana-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/12/2024 17:31:12

lexaria-bioscience-hires-contract-research-organization-to-perform-cos-next-glp-1-human-pilot-study
Lexaria Bioscience Hires Contract Research...
03/07/2024 14:08:10

maxim-group-maintains-buy-on-lexaria-bioscience-raises-price-target-to-12
Maxim Group Maintains Buy on Lexaria Biosc...
03/05/2024 16:41:51

Maxim Group analyst Michael Okunewitch maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and raises the price target fro...

watching-lexaria-bioscience-traders-circulate-analyst-comments-suggesting-dehydratech-platform-for-the-delivery-of-glp-1-drugs-with-a-comprehensive-development-program-could-produce-a-compelling-data-package-to-partner-the-technology
Watching Lexaria Bioscience; Traders Circu...
03/05/2024 16:27:35

Core News & Articles
Lexaria To Begin Diabetes And Weight Loss ...
03/05/2024 14:10:01

Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be testedChronic dosing over a 12-week treatment periodWill asse...

lexaria-announces-fda-clearance-for-its-planned-us-phase-1b-hypertension-clinical-trial
Lexaria Announces FDA Clearance For Its Pl...
03/01/2024 13:22:01

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 21:31:08

why-lexaria-bioscience-lexx-shares-are-moving
Why Lexaria Bioscience (LEXX) Shares Are M...
02/15/2024 14:27:48

Lexaria Bioscience shares are trading lower by 6.5% Thursday morning. The company finalized agreements for a registered direct ...

lexaria-bioscience-announces-36m-registered-direct-offering-of-1558443-shares-at-231share
Lexaria Bioscience Announces $3.6M Registe...
02/15/2024 13:21:02

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/09/2024 17:31:35

lexarias-submits-investigational-new-drug-application-for-planned-phase-1b-trial-of-dehydratech-cbd
Lexaria's Submits Investigational New Drug...
01/30/2024 13:55:11

lexaria-bioscience-unveils-planned-2024-glp-1-study-program
Lexaria Bioscience Unveils Planned 2024 GL...
01/16/2024 14:14:07

Extensive work program designed to support commercial discussions.

lexaria-bioscience-corp-proprietary-drug-delivery-system-improves-way-molecules-enter-bloodstream
Lexaria Bioscience Corp. Proprietary Drug-...
01/11/2024 13:43:52

Lexaria Bioscience Corp. (NASDAQ:LEXX) announces the availability of a broadcast titled, "Exciting New Cures Possible from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION